26 reports

Gastric cancer

4546 5000 3864

However, gastric cancer survival rates still lag significantly behind many other highincidence cancers such as colorectal cancer, breast cancer, and prostate cancer (SEER, 2016).

  • Cancer
  • Asia
  • Japan
  • Eli Lilly & Co.
  • Merck & Co., Inc.

Head and neck cancer

4546 5000 3864

National Cancer Institute (2016) Head and Neck Cancer.

  • Cancer
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Eli Lilly & Co.
  • Merck & Co., Inc.

Pancreatic cancer

4546 5000 3864

Cancer Research UK (2016a) Pancreatic cancer symptoms.

  • Cancer
  • Celgene Corporation
  • Gilead Sciences, Inc.
  • NewLink Genetics Corporation
  • Taiho Pharmaceutical Co., Ltd.

Colorectal cancer

4546 5000 3864

National Cancer Institute (2014a) Colorectal cancer.

  • Cancer
  • Europe
  • Japan
  • World
  • Taiho Pharmaceutical Co., Ltd.

American Cancer Society (2016) Liver Cancer.

  • Cancer
  • Europe
  • Japan
  • ArQule, Inc.
  • Eli Lilly & Co.

National Cancer Center (2013) Cancer Statistics in Japan.

  • Cancer
  • Europe
  • Japan
  • GlaxoSmithKline plc
  • Roche Group

Renal cell cancer

4546 5000 3864

American Cancer Society (2016) Kidney Cancer ACS.

  • Cancer
  • Asia
  • Europe
  • Japan
  • World

American Cancer Society (2015a) Cancer Facts & Figures.

  • Cancer
  • Europe
  • Japan
  • AstraZeneca PLC
  • TESARO, Inc.

Prostate cancer

4546 5000 3864

MD Anderson Cancer Center (2015) Prostate Cancer.

  • Cancer
  • Europe
  • Japan
  • World
  • PROVENGE group

In order to accurately size the at-risk population, Datamonitor Healthcare identified key cancers to include in this analysis; the eight cancers selected were bladder cancer, breast cancer, colorectal cancer, gastric cancer, head and neck

  • Cancer
  • Europe
  • Japan
  • Amgen Inc.
  • Galenica Group

American Cancer Society (2016b) Cancer Facts & Figures.

  • Cancer
  • Europe
  • ARIAD Pharmaceuticals, Inc.
  • Novartis AG
  • Pfizer Inc.

Cancer, ##, ##-##.

  • Cancer
  • Amgen Inc.
  • ARIAD Pharmaceuticals, Inc.
  • Novartis AG
  • Pfizer Inc.

Cancer Research, (suppl. ) ##, ##s.

  • Cancer
  • Europe
  • Celgene Corporation
  • Pfizer Inc.
  • Roche Group

Cancer Research, (suppl. ) ##, ##s.

  • Cancer
  • Europe
  • Japan
  • Celgene Corporation
  • Roche Group

Cancer Research, (suppl. ) ##, ##s.

  • Cancer
  • Europe
  • Japan
  • Biogen Idec Inc.
  • Roche Group

Human papillomavirus (HPV) is a major cause of the main types of cervical cancer (the two main histological subtypes being squamous cell cancer and adenocarcinoma), and is believed to be responsible for around ##% of cervical cancers.

  • Cancer
  • Cervical Cancer
  • Pathology
  • Europe
  • Japan

Market Spotlight: Cervical Cancer ## KEY TAKEAWAYS ## DISEASE BACKGROUND ## TREATMENT ## Surgery ## Radiotherapy ## Chemotherapy ## Targeted therapy ## EPIDEMIOLOGY ## MARKETED DRUGS ## Approvals by country ## PIPELINE DRUGS ## KEY UPCOMING EVENTS ## LICENSING AND ASSET ACQUISITION DEALS ## Alligat

  • Cancer
  • Cervical Cancer
  • Pathology
  • Forecast

More than ##% of lung cancers are non-small cell lung cancers (NSCLC), with the exact proportion depending on the country in question.

  • Cancer
  • Lung Cancer
  • Europe
  • Japan
  • Demand

Renal cell cancer (RCC) disease forecast and market analysis to 2035 CONTENTS (Full Disease Coverage) ## FORECAST: RENAL CELL CANCER ## Executive Summary ## Market Overview and Trends ## Methodology and Market Definition ## Afinitor (everolimus) ## AGS-## ## atezolizumab ## Avas

  • Cancer
  • Renal Cancer
  • Europe
  • Japan
  • Demand

AMERICAN CANCER SOCIETY (2016) PROSTATE CANCER.

  • Cancer
  • Tuberculosis
  • Europe
  • Spain
  • United States

cancer (NSCLC) Bladder cancer Looking forward: the future of immuno-oncology PD-##/ PD-L## Inhibitors: The First Major Wave of Immuno-Oncology Since Opdivo (nivolumab; Bristol-Myers Squibb/ Ono Pharmaceutical) first gained Japanese regulatory approval for the treatment of m

  • Cancer
  • Japan
  • United Kingdom
  • United States

AMERICAN CANCER SOCIETY (2015) CANCER FACTS AND FIGURES 2015.

  • Cancer
  • Hospital
  • Oncology
  • United States
  • Aetna Inc.

NHS (2015A) NATIONAL CANCER DRUGS FUND LIST VER##. ##.

  • Cancer
  • Europe
  • Celgene Corporation
  • Humana Inc.
  • Takeda Pharmaceutical Company Limited

This will be facilitated by the availability of Avastin through previous EMA approvals for the treatment of colorectal cancer, non-small cell lung cancer, renal cell cancer, ovarian cancer, breast cancer, and cervical cancer.

  • Cancer
  • Europe
  • Japan
  • Product Initiative
  • Merck & Co., Inc.

THE BIG PHARMA FIRM MAY DEVELOP FPA## ALONE OR IN COMBINATION; THE COMPANIES HAVE ALREADY STARTED A PHASE IA/ IB TRIAL OF AN FPA##/ OPDIVO COMBINATION IN NON-SMALL CELL LUNG CANCER, MELANOMA, HEAD AND NECK CANCER, PANCREATIC CANCER, COLORECTAL CANCER, AN

  • Bladder Cancer
  • Cancer
  • United Kingdom
  • United States
  • Deals & Alliance

IN ADDITION TO FURTHER APPROVALS FOR NSCLC, APPROVALS FOR RENAL CELL CANCER, BLADDER CANCER, GASTRIC CANCER, HEAD AND NECK CANCER, AND TRIPLENEGATIVE BREAST CANCER ALL SEEM LIKELY.

  • Cancer
  • Cell Therapy
  • United States
  • Product Initiative
  • Bristol-Myers Squibb Company